Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
22.64
+0.57 (2.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
Neurogene Employees
Neurogene had 91 employees as of December 31, 2023. The number of employees increased by 9 or 10.98% compared to the previous year.
Employees
91
Change (1Y)
9
Growth (1Y)
10.98%
Revenue / Employee
$10,165
Profits / Employee
-$36,000
Market Cap
335.72M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 91 | 9 | 10.98% |
Dec 31, 2022 | 82 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Revance Therapeutics | 597 |
Spok Holdings | 384 |
NeuroPace | 171 |
Absci | 155 |
Acelyrin | 135 |
Olema Pharmaceuticals | 74 |
Jasper Therapeutics | 45 |
Candel Therapeutics | 42 |
NGNE News
- 23 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Shareholders to Reach Out - Accesswire
- 24 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 25 days ago - Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 26 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Shareholders to Inquire about Securities Investigation - Accesswire
- 27 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Investors to Connect - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Stockholders to Inquire about Securities Investigation - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Investors to Learn More About the Investigation - Accesswire
- 4 weeks ago - Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire